Dr. Lombardi presented at the 2016 American Association of Immunologists annual meeting in Seattle, Washington. Dr. Lombardi presented data supporting a model of gut pathology in ME/CFS whereby dysregulated pDCs fail to promote the production of low-affinity IgA through the process of TI activation of B cells, thereby leading to bacterial overgrowth, dysbiosis, bacterial translocation and systemic immune activation.